Skip to main content
GutCited

L-Glutamine для Crohn's Disease

C

Small RCTs show glutamine (0.5 g/kg/day) improves intestinal permeability and morphology in Crohn's patients. Evidence limited by small sample sizes.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dl\u002Dglutamine\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Итог

Small RCTs show glutamine (0.5 g/kg/day) improves intestinal permeability and morphology in Crohn's patients. Evidence limited by small sample sizes.

Key Study Findings

Other
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.
Dose: None или: None Outcome: Gut microbiota composition Эффект: None None

Популяция: Crohn's disease patients

Other
Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes.
Dose: None или: None Outcome: Cholesterol levels Эффект: None None

Популяция: Mouse model

Controlled Clinical Trial
Washed microbiota transplantation for Crohn's disease: A metagenomic, metatranscriptomic, and metabolomic-based study.
Dose: Washed microbiota transplantation (WMT) или: Pre-treatment baseline Outcome: Clinical remission and multi-omics changes Эффект: None None

Популяция: Patients with Crohn's disease

In Vitro
Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production.
Dose: Beclin1 constitutive activation (genetic) или: Wild-type mice Outcome: Cytokine production in macrophage activation Эффект: None None

Популяция: Beclin1 variant mice + AIEC infection

Observational Study n=262
Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn's Disease and Exacerbates Colitis in …
Dose: Phenylacetylglutamine (PAGln, measured) или: Healthy controls (n=126) Outcome: PAGln association with CD and colitis Эффект: None None

Популяция: New-onset treatment-naive CD (n=136) + controls

Observational Study
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
Dose: None или: None Outcome: CAM use patterns in IBD patients Эффект: None None

Популяция: Brazilian IBD patients

Key Statistics

3

Исследования

200

Участники

Positive

C

Оценка

Referenced Papers

Cannabis and cannabinoid … 2024 10 цитирований
Sheng wu gong … 2022 4 цитирований
Arquivos de gastroenterologia 2022 4 цитирований
Clinical nutrition ESPEN 2021 39 цитирований
Journal of cellular … 2019 23 цитирований
The Cochrane database … 2018 425 цитирований
Gastroenterology clinics of … 2018 67 цитирований
Current opinion in … 2017 37 цитирований
JPEN. Journal of … 2017 24 цитирований
The Cochrane database … 2016 37 цитирований
Scandinavian journal of … 2014 56 цитирований
Inflammatory bowel diseases 2010 89 цитирований
Nutrition in clinical … 2009 36 цитирований
Molecular nutrition & … 2008 26 цитирований
The Cochrane database … 2007 192 цитирований
Current opinion in … 2005 22 цитирований
JPEN. Journal of … 2005 19 цитирований
Clinical nutrition (Edinburgh, … 2004 18 цитирований
Medycyna wieku rozwojowego 2004 1 цитирований
Alimentary pharmacology & … 2003 179 цитирований
Revista do Hospital … 2002 39 цитирований
Current opinion in … 2002 1 цитирований
Current opinion in … 2002
The Cochrane database … 2001 149 цитирований
Current opinion in … 2000 21 цитирований
JPEN. Journal of … 2000 18 цитирований
Diseases of the … 1998 26 цитирований
Zeitschrift fur Gastroenterologie 1998 18 цитирований
Schweizerische medizinische Wochenschrift. … 1996

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
5-15 g/day
ibsdsupport:
5 g three times daily (15 g/day total)
postexercisegut:
0.25-0.9 g/kg before intense exercise
gutbarriersupport:
0.5 g/kg/day (approximately 30-40 g/day for adults)

Верхний предел: Generally well-tolerated up to 0.5 g/kg/day; caution above 40 g/day

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Positive --
None -- Positive --
Washed microbiota transplantation (WMT) -- Positive --
Beclin1 constitutive activation (genetic) -- Positive --
Phenylacetylglutamine (PAGln, measured) -- Negative 262
None -- Mixed --
None -- Negative --
None -- Mixed --

Лучшее время приёма: Between meals or before exercise; divide doses throughout the day

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Mild gastrointestinal discomfort at high doses
  • Headache
  • Dizziness at very high doses
  • Potential glutamate excitotoxicity concerns in neurological conditions (theoretical)

Известные взаимодействия

  • Lactulose (glutamine may reduce the efficacy of lactulose for hepatic encephalopathy)
  • Anti-seizure medications (glutamine converts to glutamate; theoretical concern)
  • Chemotherapy agents (glutamine may protect cancer cells; discuss with oncologist)

Допустимый верхний уровень потребления: Generally well-tolerated up to 0.5 g/kg/day; caution above 40 g/day

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does L-Glutamine help with Crohn's Disease?
Based on 3 studies with 200 participants, there is limited but promising evidence that L-Glutamine may support Crohn's Disease management. Our evidence grade is C (Some Evidence).
How much L-Glutamine should I take for Crohn's Disease?
Studies have used various dosages. A commonly studied range is 5-15 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of L-Glutamine?
Reported side effects may include Mild gastrointestinal discomfort at high doses, Headache, Dizziness at very high doses, Potential glutamate excitotoxicity concerns in neurological conditions (theoretical). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for L-Glutamine and Crohn's Disease?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.